Results 251 to 260 of about 77,953 (304)

Tuberculous mastitis, the great imitator in breast disease: a case report with diagnostic and therapeutic challenges. [PDF]

Infect Dis Poverty
Vita S, Piccolo C, Maffongelli G, Villanacci A, Fusco N, Scorzolini L, Palazzolo C, Petrone A, Corpolongo A, Nisii C, Albarello F, Zobel B, Svegliati F, Del Nonno F, Colombo D, Di Cesare F, Nicastri E, Ianniello S.   +17 more
europepmc   +1 more source

Peripheral blood B-cell compartment dysregulation in multidrug-resistant tuberculosis is associated with reduced circulating marginal zone-like B cells. [PDF]

Front Immunol
Liu M, Wen J, Gao Q, Xu T, Lan Y, Meng L.   +5 more
europepmc   +1 more source

Clinical scoring systems for diagnosing tuberculous meningitis: A systematic review. [PDF]

World J Crit Care Med
Teo E, Kung K, Chen S, See KC.
europepmc   +1 more source

Chasing shadows: case series of six posterior segment manifestations of ocular tuberculosis. [PDF]

AME Case Rep
Faneli AC, Souza GM, Neto PFS, Finamor LP, Oliveira RDC, Muccioli C.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Patch testing versus interferon‐gamma release assay in evaluation of drug eruptions

Fundamental & Clinical Pharmacology, 2021
AbstractDelayed‐onset T‐cell‐mediated cutaneous adverse drug reactions are an uncommon but potentially serious result of medication exposures. Identification of culprit medications is crucial, but clinical diagnosis is often difficult. Patch tests and interferon‐gamma release assays (IFNγ‐RA) were previously reported as potentially useful ancillary ...
Yehonatan Kaplan, Ilan Goldberg, Eli Sprecher, Dan Slodownik   +3 more
openaire   +2 more sources

Tuberculin skin test versus interferon-gamma release assays

Acta Clinica Belgica, 2014
Dear Editor,We would like to discuss on the publication on ‘Tuberculin skin test versus interferon-gamma release assays.’1 De Keyser et al.
S S, Tin, V, Wiwanitkit
openaire   +2 more sources